LOGO
LOGO

European Economic News

European Leveraged Buyouts' Refinancing Burden Challenging, Moody's Says

By RTTNews Staff Writer   ✉  | Published:  | Google News Follow Us  | Join Us
rttnewslogo20mar2024

Moody's Investors Service on Tuesday said that the refinancing burden of unrated European leveraged buyouts remains challenging.

According to Moody's, at least a quarter of 254 companies, facing EUR 133 billion in LBO-related debt maturing through 2015 could default.

"Over half the debt maturing through 2015 is concentrated in 36 companies, each of which has over EUR 1 billion of debt," said Chetan Modi, Head of Moody's European leveraged finance and author of the report.

Although the results of the latest study are consistent with the rating agency's previous analyses, these companies are now one year closer to the 2014-15 refinancing peak. The refinancing peak remains worrisome, given the weak macroeconomic environment and the generally low credit quality of this debt, the agency observed.

Many larger companies will seek to refinance with high-yield bond. Further, more companies will attempt to amend-and-extend loans in 2012.

For comments and feedback contact: editorial@rttnews.com

Economic News

What parts of the world are seeing the best (and worst) economic performances lately? Click here to check out our Econ Scorecard and find out! See up-to-the-moment rankings for the best and worst performers in GDP, unemployment rate, inflation and much more.

Global Economics Weekly Update - Jun 01 - Jun 05, 2026

June 05, 2026 16:18 ET
A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.

Latest Updates on COVID-19